CLINICAL_TRIALS
trial_result
· 2018-09-28
Clinical Trial Update: Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia [Phase 3]
Summary
Phase 3 long-term study of RBP 7000 in schizophrenia has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indivior Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2018-09-28